BRWRX | FAFGX | BRWRX / FAFGX | |
Total Expense Ratio | 1.39 | 0.40 | 347% |
Annual Report Gross Expense Ratio | 1.43 | 0.40 | 357% |
Fund Existence | 10 years | 5 years | - |
Gain YTD | 14.298 | 18.154 | 79% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 465M | 337B | 0% |
Annual Yield % from dividends | 0.00 | 0.50 | - |
Returns for 1 year | 14.15 | 11.86 | 119% |
Returns for 3 years | 94.96 | 74.25 | 128% |
Returns for 5 years | 47.28 | N/A | - |
Returns for 10 years | 168.15 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ASLV | 27.32 | 0.23 | +0.85% |
Allspring Special Large Value ETF | |||
PKW | 130.29 | 0.78 | +0.60% |
Invesco BuyBack Achievers ETF | |||
IBRN | 28.84 | N/A | N/A |
iShares Neuroscience and Healthcare ETF | |||
MMD | 15.05 | -0.06 | -0.40% |
NYLI MacKay DefinedTerm Muni Opportunities Fund | |||
VLT | 11.01 | -0.17 | -1.53% |
Invesco High Income Trust II |